HANGZHOU THINHEAL PHARMA-TECH CO LTD
Overview
HANGZHOU THINHEAL PHARMA-TECH CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering LINACLOTIDE; RETATRUTIDE; SEMAGLUTIDE; TIRZEPATIDE.
API / Drug Master Files
HANGZHOU THINHEAL PHARMA-TECH CO LTD holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- RETATRUTIDEActive2025-12-30
- TIRZEPATIDEActive2024-06-28
- LINACLOTIDEActive2024-06-28
- SEMAGLUTIDEActive2024-06-28
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to HANGZHOU THINHEAL PHARMA-TECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.